Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SKYE

Skye Bioscience, Inc.

CIK 0001516551 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.28
↓ 0.00 (-0.14%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$9.84M
P/E Ratio
-0.19
EPS
-1.41
Dividend Yield
Not covered
52W Position
1%
Beta
1.03

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-19.79
P/S
Not covered
EV/Revenue
Not covered
ROE
10153.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.26$4.99

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$55.92M
Total Assets
$28.31M
Free Cash Flow
-$43.07M

Recent news